Medical site, treatment of disease.

Founder Of The Royal Pharmaceutical Society Commemorated In Tunbridge Wells

The 150th anniversary of the death of Jacob Bell, founder of the Royal Pharmaceutical Society of Great Britain, was remembered on Friday 12 June at a ceremony at his memorial in Woodbury Park Cemetery, Royal Tunbridge Wells.
diet pills

Long-Term Changes In Bone Mineral Density And Predicted Fracture Risk In Patients Receiving Androgen-Deprivation Therapy For Prostate Cancer

UroToday.com - In the online edition of the British Journal of Urology International, Dr. Vivek Wadhwa and colleagues report on the relationship between androgen deprivation therapy (ADT) and changes in bone mineral density (BMD). Skeletal-related fractures are more common due to osteoporosis rather than cancer in men with metastatic prostate cancer (CaP). The authors point out that measurement of BMD predicts fracture risk as accurately as blood pressure predicts stroke. Their goal was to study the long-term effects of LHRH agonist and antiandrogen therapy on BMD of selected groups of men with newly diagnosed advanced CaP, stratified by BMD at presentation and to predict alterations in fracture risk.

News of the day

Strativa's New Drug Application For Ondansetron Orally Dissolving Film Strip Accepted By FDA

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ondansetron orally dissolving film strip (ODFS). Strativa is seeking approval of ondansetron ODFS for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.